At Deliverect, our API-first platform is revolutionizing commerce by providing a connected suite of on and off-premise solutions. We empower both the food and retail industries to expand their revenue and simplify their operations, creating seamless
Location: Gent, Belgium Start date: September 2026 Duration: 6 months Work Model: On-site Work Pattern: Full Time/40 h per week About the job As our Research Intern, youll join an R&D laboratory environment focused on experimental
Who we are DoubleVerify is an Israeli-founded big data analytics company (Stock: NYSE: DV). We track and analyze tens of billions of ads every day for the biggest brands in the world. We operate at a
Join Our Team and Play a Key Role in International Trade! Are you an organized, detail-oriented professional with a passion for administration and customer service? Do you thrive in a dynamic environment where accuracy, communication, and
Who we are OTIV is a Ghent-based company leading the autonomous revolution in rail. We are on a mission to increase safety and efficiency of railway operations by teaching rail vehicles to drive autonomously. By making
Earliest Start Dates: 06 July 2026 or 27 July 2026 Ready to Trade Rainy Commutes for the Spanish Lifestyle? Let’s be real: waking up to gray skies gets old. Imagine finishing your workday, closing your laptop,
Are you an experienced Finance Business Partner with a passion for innovation and life sciences? Do you enjoy partnering with senior stakeholders, influencing strategic investment decisions, and supporting the development of breakthrough therapies? Interested in this
Who we are OTIV is a Ghent-based company leading the autonomous revolution in rail. We are on a mission to increase safety and efficiency of railway operations by teaching rail vehicles to drive autonomously. By making
Are you an experienced Finance Business Partner with a passion for innovation and life sciences? Do you enjoy partnering with senior stakeholders, influencing strategic investment decisions, and supporting the development of breakthrough therapies? Argenx is looking